Leaders in the field of regenerative medicine spoke about the potential to transform medicine through new treatments that focus not just on treating disease - but on cures - at the first annual Translational Regenerative Medicine Forum. Attended by more than 400 people from across the world, the event was sponsored by the Regenerative Medicine Foundation and took place last week in Winston Salem, North Carolina, USA.
"We are excited to bring together representatives from all facets of this emerging field to discuss the body's ability to heal itself through regenerative medicine technologies," said DaLaura Kader, vice president for strategic initiatives for the Regenerative Medicine Foundation.
Speakers covered current research and discussed best practices and business models to bring new therapies to patients. Regenerative medicine focuses on developing replacement tissues and organs in the laboratory as well as cell therapies to restore function.
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Login to your accountTry before you buy
7 day trial access
Become a subscriber
Or £77 per month
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
Copyright © The Pharma Letter 2025 | Headless Content Management with Blaze